Medico RemediesNSE:MEDICO -1.88%86 Net Margin % is 10.31% as of Mar. 2026, which is 192% above its 10-year median of 3.53. GuruFocus rates NSE:MEDICO with a GF Score™ of 86/100 and a GF Value™ of ₹75.89 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Medico Remedies ranks better than 52.72% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Medico Remedies's Net Income for the
three
months ended in Mar. 2026 was ₹59 Mil. Medico Remedies's Revenue for the
three
months ended in Mar. 2026 was ₹568 Mil. Therefore, Medico Remedies's net margin for the quarter that ended in Mar. 2026 was 10.31%.
The historical rank and industry rank for Medico Remedies's Net Margin % or its related term are showing as below:
NSE:MEDICO'
s Net Margin % Range Over the Past 10 Years
Min: 1.61 Med: 3.53 Max: 6.69
Current: 6.36
NSE:MEDICO's Net Margin % is ranked better than 52.72% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs NSE:MEDICO: 6.36
Medico Remedies (NSE:MEDICO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Medico Remedies Net Margin % Related Terms
Medico Remedies Net Margin % Historical Data
* Premium members only.
The historical data trend for Medico Remedies's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Medico Remedies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medico Remedies Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medico Remedies's Net Margin % distribution charts can be found below:
* The bar in red indicates where Medico Remedies's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medico Remedies (NSE:MEDICO) has a Net Margin % of 10.31% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Medico Remedies and its competitors. This is 192% above median its historical median of 3.53. Over the past decade, Medico Remedies' Net Margin % has ranged from 1.61 to 6.69. According to the industry distribution chart, Medico Remedies ranks #452 out of 956 companies in the Drug Manufacturers industry, placing it in the top 47.3%.
Is Medico Remedies' Net Margin % too high?
Medico Remedies' current Net Margin % of 10.31% is 192% above median its 10-year median of 3.53. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 6.69. The Drug Manufacturers industry median Net Margin % is 5.56. Medico Remedies' value of 10.31% is 85.4% above this industry median. Based on the distribution chart, Medico Remedies ranks #452 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Medico Remedies has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medico Remedies ranks #452 out of 956 companies for Net Margin %. This puts Medico Remedies in the upper half of its industry. The industry median Net Margin % is 5.56. Medico Remedies' value of 10.31% is 85.4% above this benchmark. Historically, Medico Remedies' own Net Margin % has ranged from 1.61 to 6.69 over the past decade. While the company's 10-year median is 3.53 vs. the industry median of 5.56, Medico Remedies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medico Remedies's current Net Margin % of 10.31% is 85.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medico Remedies and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medico Remedies's current Net Margin % is 10.31%, which is 192% above median its own 10-year median of 3.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹75.89, compared to a current price of ₹40.28 — trading 46.9% below its estimated fair value. The current Net Margin % is 10.31%, which is 192% above median its 10-year median of 3.53 and 85.4% above the Drug Manufacturers industry median of 5.56. Medico Remedies' overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Net Margin % is 10.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?
Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued.
The current stock price of ₹40.28 is trading 46.9% below its estimated GF Value™ of ₹75.89.
GuruFocus considers Medico Remedies to be Significantly Undervalued.
Key valuation signals for NSE:MEDICO:
Net Margin %: 10.31% (192% above median its 10-year median of 3.53)
GF Value™: ₹75.89 vs. price of ₹40.28 (46.9% below fair value)
Industry Position: 85.4% above the Drug Manufacturers median (#452 of 956)
No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
86GF Score
Get the complete analysis for NSE:MEDICO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDICO has been successfully added to your 
